Skip to content
ProPublica Donate
ProPublica Donate
Photo of ProPublica

ProPublica

ProPublica is an independent, nonprofit newsroom that produces investigative journalism with moral force. Learn more.

Lost to History

Congressmen to Hagel: Where Are the Missing War Records?

Unsatisfied with answers so far, leaders of the House veterans’ panel ask defense Secretary Chuck Hagel to explain why Army units can’t find field records from Iraq and Afghanistan.

Patient Safety

Your Hospital May Be Hazardous To Your Health

As part of our ongoing investigation into patient safety, ProPublica reporters Marshall Allen and Olga Pierce produced this interactive story in collaboration with PBS Frontline and Ocupop during a May 11-16 hackathon.

The Prescribers

FAQ: What You Need to Know About Prescriber Checkup

Frequently asked questions about our Prescriber Checkup news application.

Tracking State Bills Takes a Village: The Legislature Tracker Gets Launched in N.Y.

The MinnPost's open source Legislature Project makes it easy for newsrooms and individuals to identify and keep track of bills. Welcome, New York edition.

Out of Order

Reversal of Fortune: A Prosecutor on Trial

In the world of abusive prosecutors – where evidence can be withheld or invented in the name of winning convictions and without fear of punishment – Ken Anderson stands out: Anderson, a Texas prosecutor who abused his authority to help send an innocent man to prison for decades, now faces 10 years behind bars for his misconduct.

Have You Worked With a Temp Agency? Help Us Investigate

FDA Approved New Drug Despite Ongoing Investigation of Lab Misconduct

We’ve reported that the FDA has allowed drugs to stay on the market despite the fact that the research underpinning their safety and efficacy was tainted by fraud. New information shows that even after the FDA had cited the lab for falsifying data, the agency issued at least one brand new approval to a drug tested there.

A Reading Guide to What's Going on in Boston

As the hunt for suspects in the Boston bombings continues, we’ve pulled together some of the best reporting so far and who to follow for breaking news.

Double Dose: In Second Case of Flawed Drug Research, FDA Response Was Slow and Secretive

This week ProPublica reported that the Food and Drug Administration found "egregious" research violations at a major laboratory but didn't pull any affected drugs from the market and, years later, hasn't finished its review. Turns out that wasn't an anomaly.

No Substitute: When a Generic Drug Isn't What it Seems

Generic medications are generally safe and effective, because the Food and Drug Administration requests tests to prove they're equivalent to the name-brand originals. But here's a case where something went wrong.